ANI Pharmaceuticals, 1610 93rd Ln NE, Blaine, MN 55449, US

Nanocopoeia is a privately held specialty research company based in St. Paul, MN, specializing in solving high-value high-barrier, insolubility, bioavailability, and related drug product issues. With a strong proof-of-concept in enhancing low solubility drug performance and solid progress across their target drug pipeline, Nanocopoeia has demonstrated product enhancements that span patient safety, convenience, compliance, and effectiveness. Founded in 2001 through a technology license with the University of Minnesota, Nanocopoeia initially focused on medical devices and advanced nano-scale coating processes within a business-to-business technology services model. However, they recently reorganized and restructured to scale-up technology and generate macro-particles for oral-solid drug development, attracting substantial investment from investors and building a technically accomplished team and experienced industry management to create valuable opportunities.Generated from the website